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Abstract 
Autophagy, the catabolic process through which intracellular constituents are degraded 
in the lysosome under nutrient starvation or stress, has gained growing attention in the 
field of diabetes and obesity (Goldman S 2010; Ost A 2010; Beau I 2011; Kovsan J 
2011). Despite the fundamental cellular function of autophagy in maintaining cellular 
energy homeostasis and survival under nutrient- or energy-deprived conditions and 
stress, the role of adipose autophagy in metabolism and metabolic diseases remains 
largely unknown.  The goal of my study has been to better understand the function of 
autophagy in adipogenesis and in the regulation of adipocyte metabolism.  My study has 
been focused on defining the role of ULK1 (Unc-51 like kinase 1, mammalian homolog 
of Atg1, hATG1) and its homologue ULK2 in the regulation of adipogenesis, 
metabolism and mitochondrial functions in adipocytes. ULK1 and ULK2 are key 
regulators of autophagy induction in mammalian cells (Kundu M 2009; Chang YY 
2009; Ganley IG 2009; Hosokawa N 2009; Jung CH 2009).  Knockdown of ULK1 or 
ULK2 inhibited autophagy in 3T3-L1 adipocytes, suggesting that they play important 
roles in autophagy in adipocytes.  The knockdown experiment also revealed that ULK1 
and ULK2 share key functions in lipolysis, mitochondrial respiration and protection of 
cells against oxidative stress.  Despite these shared functions, their knockdown had 
different or even opposing effects on several metabolic parameters.  Knockdown of 
ULK1 raised PPAR-γ level, facilitated differentiation of 3T3-L1 cells, increased the 
levels of GLUT4, insulin receptor β (IRβ) and insulin receptor substrate-1 (IRS-1), and 
insulin-stimulated glucose uptake, and reduced fatty acid oxidation. By contrast, 
knockdown of ULK2 had opposite or no significant effects on these parameters. 
Through knocking down both ULK1 and ULK2, we found that ULK2 has a dominant 
effect over ULK1 in the regulation of adipogenesis.  These results demonstrate that 
ULK1 and ULK2 have distinct functions in the regulation of adipogenesis and adipocyte 
metabolism, and that ULK2-dependent autophagy appears to be important for 
adipogenesis.  
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CHAPTER 1 : Introduction 
 
1.1. Adipose tissue - a central organ responsible for energy metabolism and 
homeostasis in the body 
 
Adipose tissue plays a key role in maintaining energy homeostasis in our body by 
releasing or storing lipids in response to the body energy demand and food uptake (Fig. 
1). Adipose tissue takes up fatty acids and coverts them into triacylglycerides (TAG), the 
form of lipid stored in the tissue.  Under starvation or high energy demand, TAG is 
converted into fatty acids that are secreted for usage in other tissues.  TAG can also be 
oxidized in mitochondria to produce heat instead of ATP thereby maintaining the body 
temperature (De Pauw A 2009; Bournat JC 2010; Wang CH 2010).  The white adipose 
tissue (WAT) is responsible for storage and release of lipids, whereas the brown adipose 
tissue (BAT) is responsible for maintaining the body temperature homeostasis (Camp 
HS 2002; Rosen ED 2006; Trayhurn 2007).  Accumulation of fatty acids in other tissues 
due to metabolic problems in adipose tissue can cause hypertension, atherosclerosis, 
obesity and insulin resistance (Camp HS 2002; Gustafson 2010; Marcelin G 2010; 
Achike FI 2011) 
 
Adipose tissue also takes up glucose in response to insulin and converts it into lipid for 
storage thus playing an important role in maintaining glucose homeostasis in our body 
(Saltiel AR 2001; Rosen ED 2006; Trayhurn 2007). Although adipose tissue control 
2 
 
small portion up to 15% of glucose in the circulation, both too high fat (obesity) and too 
little fat (lipodystrophy) can cause insulin resistance.  This implies that glucose 
regulation by adipose tissue is important for glucose homeostasis in the body (Kahn 
1996; Rosen ED 2006). Thus, insulin-responsive glucose uptake by adipose tissue is 
important for our body metabolism. Supporting this notion, insulin resistance developed 
in the mice in which GLUT4, the glucose transporter responsible for insulin-stimulated 
glucose uptake in adipocytes, is deficient in adipose tissue (Abel ED 2001). 
 
Adipose tissue is important not only for energy homeostasis or the body temperature 
maintenance but also for the secretion of cytokines (called adipokines) or hormones that 
control inflammatory response in the tissue.  Adiponectin, visfatin, and omentin are 
some examples of adipokines that act as anti-hyperglycaemic factors to suppress high 
blood glucose levels. Resistin, TNFα, and interleukin-6 (IL-6) are other types of 
adipokines that act as pro-hyperglycaemic factors to raise blood glucose levels (Rosen 
ED 2006; Trayhurn 2007).  Some of adipokines are propagated to peripheral tissues and 
the brain to have a global effect on the body metabolism.  An example is leptin. Leptin is 
propagated to the hypothalamus in the brain thus affecting the appetite. 
 
Given the key functions of adipose tissue in energy homeostasis and in the development 
of many metabolic diseases, it is important to understand better how adipose tissue 
functions and metabolism are regulated and how its function is disrupted in the 
metabolic disease states.  Many of the key metabolic processes conducted by adipocytes 
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are dependent upon mitochondrial functions (Lowell 2005; De Pauw A 2009; Bournat 
JC 2010; Wang CH 2010; Achike FI 2011).  In the following section, I will briefly 
describe the functions of mitochondria in adipocytes and how my study is related to 
mitochondrial functions.   
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1.2.  Mitochondria - the key organelle for energy metabolism in adipocytes   
 
Mitochondria are the key cellular organelle responsible for production of energy (ATP), 
thus its function is crucial for cell growth, survival and other basic cellular functions 
(Fig. 2).  Mitochondria in adipocytes are important given their key role in metabolizing 
glucose and fatty acids through the TCA cycle and the oxidative phosphorylation 
(Boudina S 2005; Cheng Z 2010). Mitochondrial dysfunction is closely linked to obesity 
and insulin resistance (Bournat JC 2010; Wang CH 2010). Mitochondria are important 
not only for ATP production and energy metabolism but also for apoptotic process and 
cellular oxidative stress response.  Mitochondria play key role in apoptosis through 
releasing cytochrome c.  Mitochondria are the main source of the reactive oxygen 
species (ROS) in cells (Ueda S 2002; De Pauw A 2009; Bournat JC 2010; Circu ML 
2010; Hamanaka RB 2010; Rigoulet M 2011).  
 
Mitochondrial dysfunction is closely linked to obesity and insulin resistance (Bournat JC 
2010; Wang CH 2010).  Increased ROS, protein oxidation and cell death can be caused 
by dysfunctional mitochondria in obesity and type 2 diabetes (Lowell 2005; Grimsrud 
PA 2007; De Pauw A 2009; Wang CH 2010).   
 
ROS are short-lived and highly reactive molecules including superoxide, hydroxyl 
radicals and peroxides. They are byproducts of oxygen consumption and oxidative 
phosphorylation in mitochondria. Oxidative stress or TNFα can induce mitochondrial 
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damages which can increase the production of more ROS and protein oxidations such as 
carbonylation (Curtis JM 2010).  Thus, clearance of damaged mitochondria is important 
to suppress the accumulation of oxidative stress in adipocytes.  
 
Damaged mitochondria are known to be degraded selectively through a cellular process 
called autophagy that is the main subject of my thesis work. Given the appreciated 
importance of clearance of damaged mitochondria, it is considered to be important to 
better understand the role of autophagy in the regulation of oxidative stress response and 
metabolism in adipocytes. The following chapter will introduce the general functions of 
autophagy and the currently-known functions of autophagy in adipocytes.    
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1.3. Autophagy in adipocyte metabolism 
 
Autophagy is an evolutionarily conserved process through which cytoplasmic 
components are captured into double-membrane structures called autophagosome and 
degraded in the lysosome (Fig. 3) (Bursch W 2000; Levine B 2008; Mizushima N 2008; 
Singh R 2009). Although the origin of autophagosomal membrane remains unclear, 
several reports demonstrated that the membrane originates from endoplasmic reticulum 
(ER), Golgi, or mitochondria membrane (Weidberg H 2011). There are two types of 
autophagy; macroautophagy, and selective autophagy (Levine B 2008; Mizushima N 
2008).  Macroautophagy is a non-selective process through which intracellular 
components are randomly captured by autophagosome and degraded in the lysosomes 
during nutrient starvation.  This process is believed to be important for cell survival 
under starvation or stress or for cellular differentiation.  On the other hand, selective 
autophagy occurs to target and degrade specific cellular components and organelles (Fig. 
4). Mitophagy is an example of selective autophagy through which damaged 
mitochondria are selectively recognized by autophagosomes and degraded in the 
lysosomes. 
 
Autophagy has gained growing attention in the field of diabetes and obesity as a 
potential contributing factor to insulin resistance due to its key role in maintaining 
cellular energy homeostasis and survival and removing damaged mitochondria under 
nutrient- or energy-deprived states and stress (Goldman S 2010; Ost A 2010; Beau I 
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2011; Kovsan J 2011).  Recent studies have shown that autophagy in adipose tissue is 
perturbed in obesity and insulin resistance state. Inhibition of autophagy by 3-methyl 
adenine treatment prevented insulin receptor degradation induced by ER stress in 
adipose tissue from obese mice (Yorimitsu T 2006; Zhou L 2009; Shimada Y 2011). 
Autophagy was also up-regulated in adipose tissue of obese persons and type 2 diabetes 
patients (Ost A 2010; Beau I 2011; Kovsan J 2011).       
 
Recent studies have revealed that adipogenesis is dramatically suppressed when a key 
autophagy gene Atg5 is deficient in mouse embryonic fibroblasts (MEFs) (Baerga R 
2009). Consistent with the results from cultured adipocytes, the adipose-specific deletion 
of Atg7 resulted in lean mice and enhanced insulin sensitivity in the body (Singh R 
2009; Zhang Y 2009). The Atg7 KO mice showed reduction in the mass of WAT and an 
increase in the mass of BAT.  WAT in Atg5 or Atg7 KO mice contained adipocytes that 
have the feature of brown adipocytes with an elevated rate of fatty acid oxidation and a 
higher mitochondrial content (Singh R 2009).   
 
Although these studies have provided important insight into the role of autophagy in 
adipose development, the metabolic changes in Atg5- or Atg7-ablated mice are more 
likely attributed to the increase in BAT mass during the animal development.  It remains 
unclear how autophagy contributes to metabolic disease states that are caused by 
metabolic changes or stress at adults after development. Furthermore, a recent study 
revealed that autophagy can occur in a manner independent of Atg5/Atg7 while still 
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depending on ULK1(Nishida Y 2009).   Thus, it is necessary to study functions of ULK1 
and other autophagy proteins to better understand the roles of adipocyte autophagy in 
metabolism. 
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1.4.  ULK – the key protein kinase in the autophagy pathway 
 
ULK1 is a Ser/Thr kinase that plays a key role in inducing autophagy in response to 
starvation in a variety of cell types (Chang YY 2009; Hosokawa N 2009; Jung CH 2009; 
sokawa N 2009; Dunlop EA 2011) (Fig. 5). The human genome has five ULK1 
homologues, which are ULK1, ULK2, ULK3, ULK4 and STK36 (Ser/Thr kinase 36) 
(Jung CH 2010; N. 2010) (Fig. 6). Among them, only ULK1 and ULK2 have been 
shown to regulate autophagy in various cell types (Ganley IG 2009; Hosokawa N 2009; 
Jung CH 2009; Kundu M 2009; Egan DF 2011).  ULK1 and ULK2 form two distinct 
protein complexes by interacting with Atg13, focal adhesion kinase family interacting 
protein of 200 kD (FIP200), and Atg101 (Fig. 5) (Chan 2007; Hara T 2008; Ganley IG 
2009; Hosokawa N 2009; Hosokawa N 2009; Jung CH 2009; Mercer CA 2009; Jung CH 
2011).   ULK1 and ULK2 show 52% of identity in the amino acid sequences (Jung CH 
2010).  Although ULK1 is a key molecule in the autophagy pathway, mice lacking 
ULK1 in the whole body were viable without showing any apparent developmental 
defect (Kundu M 2009).  This might be due to a compensatory function of ULK2 for the 
loss of ULK1.   
 
ULK1 is phosphorylated by mTORC1 (mTOR complex 1) and AMPK (5’ AMP-
activated protein kinase), the key cellular nutrient and energy sensing kinases (Egan D 
2011; Egan DF 2011; Kim J 2011).   mTORC1 and AMPK have opposite effects on 
ULK1 activity.  AMPK phosphorylation of ULK1 stimulates ULK1 to trigger autophagy, 
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whereas mTORC1 phosphorylation of ULK1 prevents AMPK from binding to ULK1 
thus inhibiting autophagy induction (Kundu M 2009).   Thus, ULK1 is a key molecule 
that integrates and transmits signals from mTORC1 and AMPK to the autophagy 
machinery (Fig. 7). ULK1 also plays a critical role in the regulation of autophagic 
degradation of mitochondria (mitophagy) in maturing reticulocytes, hepatocytes, and 
fibroblasts (Kundu M 2009; Egan DF 2011). 
 
The macroautophagy or mitophagy induced by ULK1/2 complex may degrade defective 
mitochondria and other cellular structures so that it may contribute to abrogate metabolic 
problems caused by ROS. Oxidative stress such as ROS and mitochondrial dysfunction 
can be caused by alteration in lipid metabolism (De Pauw A 2009; Bournat JC 2010). 
Saturated FFA may alter lipid storage and balance in the form of TAG in adipocytes, 
which can significantly deteriorate the metabolic function of mitochondria. 
Mitochondrial dysfunction and increased glucose utilization is the featured phenotypes 
of tumor cells known as Warburg effect (Gogvadze V 2010). We assume that glucose 
transport and glycolysis may be altered as a consequence of imbalance in lipid 
metabolism and mitochondria dysfunction in adipocytes (Fig. 7). Furthermore, 
molecular mechanism of how oxidative stress and mitochondria dysfunction can affect 
the mTOR/AMPK/ULK1-regulated autophagy remains unclear (Fig. 7).  
  
ULK1 and ULK2 were shown to inhibit mTORC1 signaling (Scott RC 2007; Dunlop 
EA 2011; Jung CH 2011), which was not the case with Atg5 or other autophagy genes.   
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ULK1 binds to AMPK and phosphorylates AMPK (Löffler AS 2011).  Thus, ULK is a 
unique component in the autophagy pathway that functionally interacts with AMPK and 
mTORC1, which regulate mitochondrial biogenesis, adipogenesis and metabolism in 
adipocytes.  Based on this knowledge, it is important to investigate the role of ULK in 
adipocytes. Given that mTORC1 signaling is known to be important for adipogenesis 
(Zhang HH 2009), Whether ULK1 contributes to adipogenesis through altering 
mTORC1 signaling is an interesting question. 
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1.5.  The overall scope and the central hypothesis of my study 
 
Given the key functions of ULK1 in the regulation of autophagy and mitochondrial 
clearance, this kinase must play an important role in the regulation of adipocyte 
metabolism. I hypothesize that ULK1 may regulate adipogenesis and adipocyte 
metabolism through altering mTORC1 signaling and mitochondria function and 
metabolism.  Based on the known and anticipated functions of ULK1, I hypothesized 
that ULK1 may have critical roles in the regulation of adipocyte metabolism and 
mitochondria functions through the autophagy process. To test the hypothesis, I first 
examined the levels of autophagy-related proteins and autophagy activity in adipose 
tissue of lean and obese mice to investigate how autophagy is affected by high fat diet. 
Next, 3T3-L1 adipocytes were stably transduced by shRNA specific to ULK1 or ULK2. 
As controls, 3T3-L1 adipocytes were transduced by shRNAs for GFP (green 
fluorescence protein) or a scrambled sequence.  For comparison with other autophagy 
gene, Atg5-silenced 3T3-L1 adipocytes were also prepared.  Using the shRNA-
transduced adipocytes, I assayed autophagy, adipogenesis, insulin signaling, glucose and 
lipid metabolism, mitochondrial function and apoptotic cell death. By comparing 
metabolic assays in each ULK1, ULK2 or Atg5-silenced adipocytes, I have determined 
the unique and shared functions of ULK1 and ULK2 in adipogenesis and adipocyte 
metabolism. Knowing that ULK2 is a closely related homologue of ULK1, my study 
also investigated the functions of ULK2 along with ULK1 in the regulation of 
adipogenesis and adipocyte metabolism.   
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Figure 1.  Adipose tissue is a central organ that regulates energy metabolism and 
homeostasis in the body. Adipose tissue plays a central role in maintaining energy 
homeostasis in our body by storing or releasing lipids, uptaking glucose, and secreting 
cytokines thereby affecting insulin sensitivity and glucose and lipid metabolism and 
homeostasis in other peripheral tissues. 
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Figure 2.  Mitochondria are the cellular organelle that plays key roles in energy 
metabolism in adipocytes. Mitochondria have molecular machinery which converts the 
chemical energy of fuels, such as carbohydrates and lipids into ATP. Pyruvate oxidation, 
the tricarboxylic acid (TCA) cycle, fatty acid beta oxidation, and oxidative 
phosphorylation through the electron transport chain are the processes that occur in 
mitochondria.  Mitochondria dysfunction can cause an increase in ROS and oxidative 
stress, which can lead to insulin resistance in adipocytes (Lowell 2005; De Pauw A 
2009; Bournat JC 2010). Mitochondria also consume ATP by mediating metabolite (i.e. 
Ca++) transport through voltage-dependent anion-selective channel (VDAC). This 
metabolite transport is important for maintaining cellular metabolite homeostasis, 
protection against oxidative stress, and regulation of apoptotic cell death (Shoshan-
Barmatz V 2010). When mitochondria are damaged or treated with TNFα, mitochondria 
release cytochrome C (CytC), which induces apoptotic cell death signaling through 
apoptotic peptidase activating factor 1 (Apaf) 1 and caspases (Circu ML 2010).  LD, 
lipid droplets; Nuc,  nucleus. 
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Figure 3.  Scheme for autophagy process induced by starvation. Autophagy is an 
evolutionarily-conserved catabolic process induced by starvation through which cellular 
constituents and damaged macromolecules and organelles are degraded in the lysosome. 
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Figure 4. Types of autopahgy occurring in mammalian cells. Macroautophagy is a 
type of autophagy that randomly engulfs cytoplasmic compartments and degrades them 
during starvation, On the other hand, selective autophagy is specific to ribosomes, 
mitochondria, peroxisome, bacteria, or viruses for their degradation. Lipid droplets can 
be degraded by autophagy in starvation, which was firstly described in hepatocytes 
(Singh R 2009), and named macrolipophagy. 
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Figure 5.  ULK1 is the key protein kinase in the autophagy pathway. ULK1 is a 
Ser/Thr kinase that plays a key role in inducing autophagy in response to starvation in 
mammalian cells. ULK1 integrates and transmits signals from mTORC1 and AMPK to 
the autophagy machinery (Jung CH 2009; Egan DF 2011; Kim J 2011). Under sufficient 
nutrient condition, active mTORC1 phosphorylate ULK1 and inhibit autophagy 
induction. Under starvation condition, mTORC1 is inactive and ULK1 can induce 
autophagy. AMPK also phosphrylate ULK1 and activate autophagy induction in glucose 
starvation condition.  
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Figure 6. There are five isoforms of ULK in mammals. Schematic representation of 
domain structures of the five ULK isoforms and their homologues in yeast, C. elegans 
and Drosophila.  ULK1 and ULK2 share 52% identity in their amino acid sequences.  
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Figure 7. Regulation of autophagy and lipid metabolism in adipocytes. ULK1/2 
complex is regulated by mTOR and is important for autophagy induction (Jung CH 
2009). When ATP level is low or glucose is depleted, LKB1 phosphorylates and 
activated AMPK (Shaw RJ 2004). Activated AMPK phosphorylates ULK and induces 
macroautophagy or mitophagy (Egan DF 2011; Kim J 2011). When the lipid metabolism 
is altered in adipocytes, the ROS level may increase along with mitochondria 
dysfunction. Glucose transport and glycolysis process can be altered as a consequence of 
imbalance in lipid metabolism.  The macroautophagy or mitophagy induced by ULK1/2 
complex may degrade defective mitochondria and other cellular structures so that it may 
contribute to reduction in metabolic problems such as ROS. 
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CHAPTER 2 : ULK1 and ULK2 are important for adipocyte autophagy 
 
Introduction : Previous studies indicated that autophagy is important for adipogenesis 
and adipose metabolism (Baerga R 2009; Singh R 2009; Zhang Y 2009). In this chapter, 
my study aimed to determine how nutrient conditions affect the autophagy activity.  To 
achieve this goal, I performed experiments to monitor the autophagy activities in adipose 
tissue in mice subjected to high fat or low fat diets and adipocytes treated with 
starvation-mimicking conditions in cell culture.  Autophagy activity was assayed by 
multiple approaches including analysis of LC3 processing, the expression level of p62, 
LC3-positive autophagosomal puncta formation, and EM images of autophagosomes.  
These assays showed that autophagy in adipose tissue and adipocytes in cell culture is 
perturbed in response to the nutritional treatments.  Using adipocyte cell culture model, I 
found that ULK1 and ULK2 are important for basal and rapamycin-induced autophagy 
in adipocytes.  These results are described in detail in the following sections.   
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2.1.  Autophagy is up-regulated in adipose tissue from mice fed with high fat diet. 
 
Previous studies in adipose tissues in Atg5 or Atg7 deleted mice revealed that autophagy 
regulates adipogenesis and lipid metabolism (Baerga R 2009; Singh R 2009; Zhang Y 
2009). Assuming that various nutrient conditions may reciprocally affect the autophagy 
activity and its regulation in adipose tissues, I asked how the activity of autophagy in 
adipose tissue is affected by diet in mice.  To address the question, I designed two 
groups of mice with standard chow diet and high fat diet which represent nutritional 
status regulating autophagy activity differently in the body. 
  
Male mice strain C57BL/6J were fed normal chow (~ 4% fat by weight, Teklad) or high 
fat diet (~35 % fat by weight, F3282, BioServ) at weaning (Surwit RS 1988). Mice were 
housed on a 12-h light/dark cycle and fed ad libitum with continual access to water. At 
12 weeks of age, they were weighing 34-49 g and 26-33 g, respectively. Each group of 
mice were fasted for 4 h and euthanized by carbon dioxide.  Epididymal white adipose 
tissue (EWAT) from CHOW low fat and high fat mice were isolated and proteins were 
extracted from the prepared tissue.  The expression levels of key autophagy proteins 
such as ULK1, Atg5 and LC3 as well as key components in the insulin signaling 
pathway such as IRβ, IRS-1 and p-S6K1 were analyzed by Western blotting.  
 
We observed that microtubule-associated protein 1B light chain 3 (LC3)-I conversion to 
LC3-II, a form of LC3 modified with phosphatidylethanolamine at C-terminus, was 
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markedly increased by three fold in adipose tissue from high fat diet mice (Fig. 8A and 
B). LC3-II is associated with autophagolysosomes and known to reflect autophagy 
activity in mammalian cells (Klionsky DJ 2008; Klionsky DJ. 2008). The protein levels 
of ULK1 and Atg5 were not significantly changed by high fat diet (Fig. 8A and C), 
indicating that high fat-diet induced autophagy occurs without needing a change in the 
level of Atg5 and ULK1.  Consistent with previous reports (Um SH 2004), high fat diet 
(HFD) enhanced the phosphorylation of S6K1 while reducing the levels of IRβ and IRS-
1 (Fig. 8A). A key finding from this experiment is that autophagy activity in adipose 
tissue is responsive to the diet of mice. This result implies that adipocyte autophagy 
might play an important role for adipocytes to appropriately respond to high fat diet or 
metabolic stress.  This result is consistent with the overall hypothesis of my study. 
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Figure 8. Autophagy is increased in adipose tissue from high fat diet mice.  (A) 
EWAT from low fat or high fat diet mice was lysed in RIPA buffer.  The levels of the 
indicated proteins in tissue extracts were analyzed by Western blotting. (B) Quantitative 
analysis of LC3-II versus LC3-I on the blot from (A). Values are mean ± standard 
deviation (std.)  *, p < 0.05. (C) Quantitative analysis of ULK1 and Atg5 levels. Values 
are mean ± std.  Detailed procedures are described in Materials and Methods section. 
 
26 
 
2.2. ULK1 and ULK2 are important for basal and rapamycin-induced autophagy 
in adipocytes. 
 
In previous chapter, we observed HFD can trigger and increase autophagy activity in 
mouse adipose tissue. The increase in the autophagy activity in response to high fat diet 
supported my hypothesis that adipocyte autophagy might be important for adipocyte 
metabolism and metabolic problems associated with obesity. To determine the extent to 
which ULK1 and ULK2 affect autophagy in adipocytes, we transduced 3T3-L1 
preadipocytes by shRNA specific to ULK1 and ULK2 and induced differentiation.  As 
controls, we transduced 3T3-L1 cells by either scrambled or GFP shRNA.  To compare 
with other autophagy genes, we also prepared Atg5-silenced 3T3-L1 cells.  At day 10 
after induction of differentiation, the transduced cells showed different extents of 
differentiation.  To avoid the effects due to the different extents of differentiation on 
autophagy, we added troglitazone in the differentiation medium to equalize the extent of  
differentiation (Fig. 9).  Troglitazone is a chemical that acts as a ligand for adipocyte 
differentiation (Tontonoz P 1994; Tontonoz P 2008; Curtis JM 2010).  Basal autophagy 
was assayed by immunostaining LC3 (microtubule-associated protein 1 light chain 3)-
positive autophagosomal puncta. Knockdown of ULK1, ULK2 or Atg5 significantly 
suppressed the formation of LC3-positive puncta (Fig. 10A and B).   Knockdown any of 
the three genes reduced the level of LC3-II, a form of LC3 modified with 
phosphatidylethanolamine at C-terminus (Fig. 10C).  We also found that the expression 
level of p62/SQSTM1, a protein degraded through autophagy (Mizushima 2007), is 
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higher in ULK1, ULK2 or Atg5-silenced adipocytes compared to that in control cells 
(Fig. 10C).   EM images of autophagosomes confirmed a significant reduction in the 
number of autophagosomes in ULK1, ULK2 or Atg5-silenced adipocytes compared to 
control cells (Fig. 11A and B).  Combined, these results suggest that ULK1, ULK2 and 
Atg5 are important for basal autophagy in adipocytes. 
 
Rapamycin, a potent inducer of autophagy, increased the LC3-positive puncta formation 
in control adipocytes (Fig. 10A and B).  The puncta formation was significantly 
suppressed by knockdown of ULK1, ULK2 or Atg5.   Rapamycin increased the level of 
LC3-II in ULK1, ULK2, or Atg5-silenced adipocytes to a much lesser extent than in 
control cells.  Consistent with the marginal change of LC3-II level, rapamycin barely 
reduced p62 level in the cells where the autophagy genes were knocked down (Fig. 10C).  
The knockdown effect on LC3 processing was highest with Atg5 knockdown (Fig. 10C).  
Consistent with this finding, recent reports showed that knockdown of either ULK1 or 
ULK2 had only a moderate effect on LC3 processing in other cell types (Hosokawa N 
2009; Jung CH 2009).  This might be because ULK1 and ULK2 could compensate each 
other when either gene was knocked down.  Alternatively, the stronger effect by Atg5 
knockdown might be due to the critical function of Atg5 as part of the LC3 conjugation 
machinery (Mizushima N 2001; Tanida I 2004). Combined, these results suggest that 
ULK1, ULK2 and Atg5 are important for both basal and rapamycin-induced autophagy 
in 3T3-L1 adipocytes.   
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Figure 9. 3T3-L1 predipocytes stably transduced by shRNAs were fully 
differentiated and used for metabolic assays. (A) ULK1, ULK2 or Atg5-silenced L1 
cells and scrambled shRNA-transduced L1 cells were differentiated as described 
previously (Curtis JM 2010) in the presence of 5 μM troglitazone. (B) Quantitative 
measurement of intracellular triglyceride using Oil Red O. Values are mean ± std. from 
three independent experiments. Detailed procedures are described in Materials and 
Methods section.   
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Figure 10.  ULK1, ULK2 and Atg5 are important for autophagy in adipocytes.  (A) 
Knockdown of ULK1, ULK2 or Atg5 inhibits the formation of autophagosome in 
adipocytes.  3T3-L1 adipocytes stably transduced by lentiviral shRNA were treated with 
rapamycin or DMSO for 5 h in the presence of lysosomal inhibitors (pepstatin A and E-
64).  LC3 puncta were monitored by immunostaining endogenous LC3 using anti-LC3 
antibody (green).  Nucleus was stained by DAPI (blue). Detailed procedures are 
described in Materials and Methods section.  (B) The number of LC3 puncta was 
counted per each cell and quantitatively analyzed. The horizontal bar represents mean 
value. (C) Knockdown of ULK1, ULK2, or Atg5 suppressed the conversion of LC3-I to 
LC3-II and the autophagic degradation of p62.  LC3 and p62 in cell lysates obtained 
from (A) were analyzed by Western blotting. (D) Quantitative analysis of LC3-II level 
relative to LC3-I level.  The y-axis represents the ratio of LC3-II level versus the levels 
of LC3-I and LC3-II combined.   
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Figure 11. EM analysis of autophagosomes reveals autophagy activity in 3T3-L1 
adipocytes. (A) EM image of 3T3-L1 adipocytes (day 8 after induction of 
differentiation).  Red arrows indicate autophagosomes. LD, lipid droplets. Detailed 
procedures are described in Materials and Methods section. (B) Quantitative analysis of 
the number of autophagosomes per each cell from EM images. The horizontal bar 
represents mean value.    
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2.3. Conclusion  
 
Through the analysis of autophagy activity in adipose tissue, my study revealed that 
autophagy activity in adipose tissue was increased from mice fed with high fat diet.  The 
increase in the activity of adipocyte autophagy could be due to a cellular protective 
mechanism against the metabolic stress, rather than due to any causative effect of 
autophagy on the development of such disease states.  This effect is consistent with 
recent reports showing an increase in the activity of adipocyte autophagy in diabetic and 
obese states (Kovsan J 2011; Ost A 2010; Zhang Y 2009; Zhou L 2009).  This protective 
function of autophagy might be important especially when adipocytes are under 
metabolic stress.  Another key finding is that ULK1 and ULK2 are important for basal 
and rapamycin-induced autophagy in adipocytes. These results provided the basis on 
which my thesis studies have been developed as described in the following chapters. 
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CHAPTER 3 : Distinct functions of the ULK1 and ULK2 in adipocyte metabolism 
 
Introduction : Knowing that ULK1 and ULK2 are important for adipocyte autophagy, 
the aim of my study in this chapter was to analyze the functions of ULK1 and ULK2 in 
the regulation of adipocyte metabolism.  This chapter is focused on the distinct functions 
of ULK1 and ULK2 in the regulation of adipogenesis and adipocyte metabolism, 
whereas the following chapter is focused on the shared functions of the kinases.  I 
performed multiple metabolic assays to assess the effects of ULK1 and ULK2 
knockdown on adipogenesis, lipolysis, glucose uptake, fatty acid oxidation, fatty acid 
synthesis and mitochondrial functions.  Key findings with regard to distinct effects of 
ULK1 and ULK2 on the metabolic parameters are described in the following sections. 
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3.1. ULK1 and ULK2 have opposing effects on adipogenesis. 
 
Knowing that ULK1 and ULK2 are important for adipocyte autophagy, we inquired 
whether they are important for adipogenesis.  Because previous studies have shown that 
Atg5 and Atg7 are important for adipogenesis (Baerga R 2009; Singh R 2009; Zhang Y 
2009), we anticipated that knockdown of ULK1 or ULK2 would affect adipogenesis.   In 
the experiment above, we treated cells with TZD to achieve full differentiation.  To 
assess the extent of differentiation, we excluded TZD in our differentiation protocol 
following the procedure described previously (Student AK 1980; Lobo S 2007).   The 
GFP-shRNA transduced 3T3-L1 cells started to show lipid accumulation at day 4 after 
induction of differentiation. Compared to the control cells, ULK1-silenced cells initiated 
the lipid accumulation earlier during the days 2 – 3 (Fig. 12).  By contrast, ULK2-
silenced cells showed a delay in lipid accumulation compared to control cells (Fig. 12). 
At day 8, we quantitatively analyzed the extent of differentiation by analyzing the lipid 
droplet contents. ULK1-silenced 3T3-L1 cells had a higher level of lipid droplet 
contents with a 11 % increase than GFP shRNA-transduced cells (Fig. 13A and B). To 
exclude any off-target effect by shRNA, we confirmed the result by using other ULK1 
shRNA with a different target site (Fig. 14).  By contrast, ULK2-silenced L1 cells had a 
lower level of lipid droplet contents with a 24 % reduction compared to control cells 
(Fig. 13A and B).  To clarify whether the effects of ULK1 and ULK2 knockdown on 
adipogenesis are related to autophagy, we analyzed the effects of knockdown of Atg5 on 
adipogenesis.  Atg5 knockdown decreased lipid droplet content by 12 %.  This result 
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suggests that ULK2 effects on adipogenesis might be related to Atg5-mediated 
autophagy.  This result is consistent with the result from other groups using Atg5 and 
Atg7-silenced adipocytes (Singh R 2009).  
 
We also analyzed differentiation marker proteins in the stable cells. Peroxisome 
proliferator-activated receptor-γ (PPAR-γ) and CCAAT/enhancer binding protein-α 
(CEBP-α) are two key transcription factors involved in adipogenesis (Tontonoz P 2008). 
We found that PPAR-γ is greatly increased in ULK1 silenced cells (Fig. 13C and 14C).  
Although the level of PPAR-γ was not increased in Atg5-silenced adipocytes, the level 
of CEBP-α p42 was increased (Fig. 13C).  In contrast, both PPAR-γ and CEBP-α were 
significantly reduced in ULK2 silenced cells, consistent with the lowest level of 
differentiation with these cells.  Sterol regulatory element-binding protein-1 (SREBP-1), 
the key transcription factor involved in lipid metabolism (Tontonoz P 2008), was not 
significantly changed by any of the knockdowns (Fig. 13C).  We found that ULK2 
knockdown increases the level of ULK1, suggesting that there is likely a compensatory 
mechanism existing between ULK1 and ULK2 (Fig. 13C).  Thus, it is possible that the 
inhibitory effect of ULK2 knockdown on adipogenesis is related to the increase in 
ULK1 level.     
 
Interestingly, when both ULK1 and ULK2 were knocked down, the differentiation was 
suppressed in a similar extent as the knockdown of ULK2 alone (Fig. 15).  This result 
suggests that the inhibitory effects of ULK2 knockdown on adipogenesis are unlikely 
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due to the increase of ULK1 level but rather due to inhibition of ULK2-dependent steps 
crucial for adipogenesis.  Given the similar effects of ULK2 and Atg5 on adipocyte 
differentiation, ULK2 rather than ULK1 is likely more closely linked to Atg5 in the 
regulation of adipocyte differentiation. 
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Figure 12. Adipocyte differentiation without troglitazone in multiple days. (A) 
ULK1, ULK2 or Atg5-silenced L1 cells and scrambled shRNA-transduced L1 cells were 
differentiated with insulin, methylisobutylxanthine, and dexamethasone, but without 
troglitazone. Detailed procedures are described in Materials and Methods section. (B) 
Measurement of intracellular triglyceride in multiple days. Values are mean ± std.  *, p < 
0.05; **, p < 0.01; ***, p < 0.001 
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Figure 13. ULK1 and ULK2 have opposite effects on adipogenesis.  (A) 3T3-L1 cells 
stably transduced by shRNA were differentiated in the absence of troglitazone.  Cells 
were stained by Oil red O at day 8 after differentiation was induced.  (B) Quantitative 
analysis of 3T3-L1 cell differentiation in the absence of troglitazone.  Intracellular 
triglyceride content was analyzed by extracting Oil Red O from cells with use of 
isopropanol and measuring the optical density of the extracted Oil Red O at wavelength 
of 490 nm. (C) Western blot analysis of protein expression in adipocytes.  Cell lysate 
was obtained from cells differentiated in the absence of troglitazone.  (D) Knockdown of 
ULK2 was confirmed by RT-PCR due to lack of antibody available to detect mouse 
ULK2.  About 85% of knockdown was confirmed for mouse ULK2 (NM_013881) by 
RT-PCR. Values are mean ± std.  *, p < 0.05; **, p < 0.01; ***, p < 0.001. Detailed 
procedures are described in Materials and Methods section. 
 
 
 
 
 
 
 
 
42 
 
 
 
 
 
43 
 
 
Figure 14. Effect of ULK1 inhibition using different sh-RNA sequence (#768) on 
adipocyte differentiation. Adipocyte differentiation was increased with the reduced 
lipid droplet size in ULK1-knocked down adipocytes when using different sh-RNA 
sequence (#768, Table S2) (A) Autophagy gene silenced cells are differentiated. Lipid 
droplet of differentiated cells was stained using Oil red O. (B) Intracellular Triglyceride 
was measured. After extracting Oil Red O from cells with isopropanol, optical density 
(OD) was measured at a wavelength of 490 nm. Values are mean ± std.  *, p < 0.05. (C) 
Protein expression levels of adipose differentiation indicators, PPAR-γ and CEBPα were 
shown by western blotting in scrambled, ULK1 (#768) silenced cells after lysed in RIPA 
buffer. Silencing of targeted ULK1 gene by #768 sh-RNA sequence was confirmed by 
western blotting in ULK1 silenced cells.   
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Figure 15. Effect of ULK1 and ULK2 double knockdown on adipocyte 
differentiation. Adipocyte differentiation was decreased in ULK1 and ULK2 double-
knocked down adipocytes (A) Both ULK1 and ULK2 silenced cells are differentiated. 
Lipid droplet of differentiated cells was stained using Oil red O. (B) Intracellular 
Triglyceride was measured. After extracting Oil Red O from cells with isopropanol, 
optical density (OD) was measured at a wavelength of 490 nm. (C) Protein expression 
levels of adipose differentiation indicators, PPAR-γ, CEBP-α, and SREBP-1 was shown 
by western blotting in scrambled, both ULK1 and ULK2 silenced cells after lysed in 
RIPA buffer. Silencing of targeted ULK1 gene was confirmed by western blotting in 
ULK1/ULK2 double-knocked down adipocytes (D) Silencing of targeted ULK2 gene 
was confirmed by RT-PCR in ULK2 silenced cells. Values are mean ± std.  *, p < 0.05 
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3.2. ULK1 plays critical roles in lipolysis and fatty acid oxidation. 
 
Noting the difference in adipogenesis in ULK1 or ULK2 knockdown adipocytes, we 
asked whether utilization of lipid as energy source has been altered in those cells (Curtis 
JM 2010).  Supporting this notion, the gene expression levels of ACC1, ACC2, and 
FASN involved in fatty acid synthesis were dramatically increased in ULK1 silenced 
cells.  In contrast, the mRNA levels of ACC2 and FASN in ULK2 silenced cells and the 
mRNA level of ACC2 in Atg5 silenced cells were reduced compared to control cells 
(Fig. 16A). Increased gene expression of fatty acid synthesis in ULK1 silenced cells and 
decreased level in ULK2 or Atg5 silenced cells correlates with the increased amount of 
fat depots in ULK1 silenced cells and decreased amount of fat depots in ULK2 or Atg5 
silenced cells (Fig. 13)   
 
Knowing that there were changes in lipid metabolism, we wondered whether fatty acid 
oxidation may also be affected.  To assess mitochondrial beta oxidation, the conversion 
of radio-labeled oleate to CO2 was assayed (Koves TR 2005). ULK1-silenced 
adipocytes exhibited 8% reduction in fatty acid oxidation of [1-14C]-oleate as determined 
by the production of 14C-labeled CO2 whereas ULK2 or Atg5 knockdown adipocytes 
had 25% and 38% increase in fatty acid oxidation, respectively (Fig. 16B). These results 
suggest that breakdown of fat depots and subsequent oxidation of fat as energy source is 
significantly enhanced by ULK2 knockdown or Atg5 knockdown whereas accumulation 
of fat depot are dominant over breakdown in ULK1 knockdown. However, when we 
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analyzed lipolysis of non-esterified fatty acids from ULK1 and ULK2 silenced 
adipocytes, the silencing of ULK1 or ULK2 led to an ~20% decrease in basal lipolysis 
(Fig. 16C). By contrast, cyclic AMP (cAMP)-dependent lipolysis was not significantly 
affected by knockdown of ULK1, ULK2 or Atg5 (Fig. 16D).  A possible role for ULK1, 
ULK2 and Atg5 in lipolysis might be related to the macroautophagic degradation of 
lipid droplets as was shown in hepatocytes (Singh R 2009).  Due to a high content of 
lipid droplets in adipocytes, we could not detect small lipid droplets.  However, we 
could observe that some small lipid droplets colocalize with autophagosome in 
adipocytes (Fig. 17).  Thus, the macroautophagic degradation of lipid droplets might be 
a possible process occurring in adipocytes.  The similar inhibitory effects on lipolysis 
between ULK1, ULK2 and Atg5 indicate that lipolysis may not be responsible for the 
different effects on differentiation.   
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Figure 16. ULK1 and ULK2 differently regulate fatty acid synthesis and oxidation, 
whereas both kinases are important for lipolysis. (A) Expression of ACC1, ACC2, 
and FASN involved in fatty acid metabolism was quantitatively analyzed by RT-PCR.  
Values are mean ± std.  *, p < 0.05; **, p  < 0.01.  (B) ULK1 enhances β-oxidation, 
whereas ULK2 reduces β-oxidation.  β-oxidation was assayed using [14C]-oleic acid.   
(C) Knockdown of ULK1, ULK2 or Atg5 reduces basal lipolysis.  3T3-L1 adipocytes 
transduced by shRNA were incubated at 37ºC in KRH supplemented with 2% fatty acid-
free BSA and 5 mM glucose.  Media was collected after 60 minutes and the non-
esterified fatty acids determined using NEFA-HR assay kit (D) Forskolin-stimulated 
lipolysis was not significantly affected by knockdown of ULK1, ULK2 or Atg5.  The 
level of fatty acids in the medium was analyzed during the indicated period of time by 
use of NEFA-HR assay kit. Values are mean ± std from three independent experiments.  
*, p < 0.05; **, p  < 0.01. Detailed procedures are described in Materials and Methods 
section.   
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Figure 17. Evidence of autophagic clearance of lipid droplet in adipocytes. Fully-
differentiated 3T3-L1 cells were cultured in the presence or absence of serum for 2 
hours.  Serum starvation is known to induce macroautophagy.  Lysosomes were stained 
using 50 nM lysotracker (Invitrogen) for 30 min, and visualized by fluorescence 
microscopy.  Lipid droplets were stained by lipid-specific dye, BODIPY (Invitrogen). 
Detailed procedures are described in Materials and Methods section. 
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3.3. Conclusion  
 
My study revealed that ULK1 has distinct functions from ULK2 and Atg5 in the 
regulation of adipogenesis and lipid metabolism in adipocytes.  ULK1 knockdown 
enhanced adipogenesis in 3T3-L1 cells, which has not been observed with other 
autophagy-related proteins.  This result suggests that autophagy activity does not 
necessarily correlate with the extent of adipogenesis, opposing the previously shown 
function of adipocyte autophagy (Baerga R 2009; Singh R 2009; Singh R 2009; Zhang 
Y 2009).   I also found that ULK1 and ULK2 have different effects on the expression of 
genes involved in fatty acid synthesis.  The up-regulation of the genes involved in fatty 
acid synthesis by ULK1 knockdown could be at least in part due to the up-regulation of 
PPAR-γ (Li AC 2004), defining a novel function of ULK1 in the PPAR-γ pathway.   We 
found that ULK1 and ULK2 have opposing effects on fatty acid oxidation and insulin-
stimulated glucose uptake.  These changes are consistent with the opposing effects of 
ULK1 and ULK2 on adipogenesis. I found that the extent of adipogenesis correlates 
well with the level of ULK2 rather than ULK1, and that ULK2 has a dominant effect 
over ULK1 in the regulation of adipogenesis. It is also noteworthy that knockdown of 
ULK2 dramatically enhanced the expression level of ULK1 while still inhibiting 
autophagy.  These results support the important function of ULK2 as a key factor 
required for autophagy and adipogenesis in adipocytes.  This function of ULK2 does not 
appear to be replaced by ULK1.    
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CHAPTER 4 : Shared functions of ULK1 and ULK2 in adipocyte metabolism 
 
Introduction : The previous chapter described that ULK1 and ULK2 have distinct 
functions in adipogenesis and lipid metabolism. This chapter is focused on the shared 
functions of ULK1 and ULK2 in the regulation of adipocyte metabolism.  I performed 
multiple metabolic assays to assess the effects of ULK1 and ULK2 knockdown on 
insulin/Akt/mTORC1 signaling activity, glucose metabolism, mitochondria functions, 
and oxidative stress response.  I found that both ULK1 and ULK2 are important for the 
mitochondrial function and oxidative stress response of adipocytes.  Key findings with 
regard to the shared effects of ULK1 and ULK2 on the metabolic parameters are 
described in the following sections. 
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4.1. ULK1 and ULK2 negatively regulate mTORC1 signaling in adipocytes.   
 
Knowing that the insulin/mTORC1 signaling pathway is important for adipogenesis 
(Zhang HH 2009), we wondered if the pathway is affected differently by ULK1 or 
ULK2 knockdown.  The fully differentiated shRNA-transduced adipocytes were treated 
with insulin and the phosphorylation states and the expression levels of Akt and S6K1 
were analyzed.  We found that knockdown of ULK1 or ULK2 enhanced the 
phosphorylation of S6K1 at Thr389 to a greater extent than control cells (Fig. 18A and 
B). These results are consistent with previous reports showing that ULK1 and ULK2 
have negative effects on S6K1 phosphorylation in 293T, HeLa, and MEFs. ULK1 
homolog Atg1 has negative effects on mTORC1 pathway in Drosophila (Lee SB 2007; 
Scott RC 2007). Although previous studies revealed that ULK1 has a direct inhibitory 
effect on mTORC1 (Dunlop EA 2011; Jung CH 2011), S6K1 phosphorylation was also 
increased by knocking down Atg5 (Fig. 18B).  Therefore, there may exist a mechanism, 
distinct from the previously-proposed one, through which autophagy regulates mTORC1 
(Dunlop EA 2011; Jung CH 2011).  On the other hand, knockdown of either ULK1 or 
ULK2 did not alter the phosphorylation status of Akt at S473.  Similarly, Atg5 
knockdown enhanced S6K1 phosphorylation to a level similar to that observed with 
ULK2 knockdown and did not have an effect on Akt phosphorylation (Fig. 18A and B).  
This suggests that the increase of S6K1 phosphorylation may occur in a manner 
independent of Akt.  Interestingly, knockdown of ULK1, but not knockdown of neither 
ULK2 nor Atg5, increased the levels of IRβ and IRS-1 (Fig. 18A and B).  Thus, it is 
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possible that the up-regulation of IRβ and IRS-1 levels and subsequent activation of 
growth factor signaling in ULK1-silenced cells might be involved in the up-regulation of 
adipogenesis, although this pathway seems not to affect Akt activation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
 
 
 
Figure 18. ULK1 and ULK2 negatively regulate the mTORC1 signaling in 
adipocytes.  (A) Knockdown of ULK1 enhances mTORC1 signaling.   3T3-L1 
adipocytes transduced by shRNA were starved of serum overnight and treated with 
insulin for the indicated period of time.  Cell extract was obtained and the expression 
levels and phosphorylation states of the indicated proteins were analyzed by Western 
blot.  (B) Knockdown of ULK2 or Atg5 enhances mTORC1 signaling in adipocytes.  
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4.2. ULK1 and ULK2 negatively regulate glucose uptake and glycolysis.  
 
Knowing that ULK1 and ULK2 regulate mTOR signaling, we inquired whether ULK1 
and ULK2 would regulate other metabolic parameters related to adipocyte metabolism. 
One of the important metabolic activities in adipocytes is glucose metabolism (Bittner 
CX 2010).  To investigate whether glucose transport is affected by ULK1 and ULK2, we 
assayed uptake of 2-deoxyglucose (2-DG), the non-hydrolyzable analog of glucose, into 
adipocytes.  2-DG uptake rate was increased by 28% in ULK1 knockdown and 23% in 
ULK2 knockdown compared to control cells (Fig. 19A). The level of glucose transporter 
(GLUT) 1 responsible for basal glucose uptake was also higher in ULK1 or ULK2 
knock downed cells (Fig. 19D). Knowing the involvement of ULK1, ULK2 and Atg5 in 
glucose transport, we assayed glycolytic rate by measuring H+ in medium.  We found 
that knockdown of ULK1, ULK2 or Atg5 increased glycolysis rate by 1.7, 1.4 and 1.8 
folds compared to control cells, respectively (Fig. 19C). Thus, the autophagy proteins 
likely affect the basal glucose uptake.  Up-regulation of GLUT1 through unknown 
mechanism might be responsible at least in part for the increase in the basal glucose 
uptake rate.    
 
We also analyzed glucose uptake rate in response to insulin.  ULK1 knockdown 
enhanced glucose uptake rate by about 1.4 fold (Fig. 19B).  On the other hand, glucose 
uptake rate in ULK2- and Atg5-silenced adipocytes was about 85% relative to that in 
control cells.  The increase by ULK1 knockdown was accompanied with an increase in 
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the expression level of GLUT4, the glucose transport responsible for insulin-stimulated 
glucose uptake (Fig. 19D).  Such an increase in GLUT4 level was not observed with 
ULK2- and Atg5-silenced adipocytes.  PPAR-γ is known to up-regulate GLUT4 
expression in adipocytes (Hamm JK 1999; Liao W 2007).  PPAR-γ that was also up-
regulated in ULK1-silenced cells (Fig. 13C and 14C).  Thus, the up-regulation of 
GLUT4 by ULK1 knockdown could be due to PPAR-γ.   
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Figure 19. ULK1, ULK2 and Atg5 negatively regulate glycolysis. (A) Knockdown of 
ULK1, ULK2, and Atg5 enhanced basal glucose uptake. Adipocytes were incubated in 
the presence of [3H]-2-deoxyglucose for 5 min.  Cells were then incubated with [3H]-2-
deoxyglucose for 5 min.  Cells were harvested and the amount of [3H]-2-deoxyglucose 
in harvested cells was assayed by using a scintillation counter.  The amount of [3H]-2-
deoxyglucose in harvested cells was assayed (n = 3). (B) Knockdown of ULK1 enhances 
insulin-stimulated glucose uptake rate, whereas knockdown of ULK2 or Atg5 
suppressed it.  Adipocytes were starved of serum overnight then stimulated with insulin 
for 60 min. (C) Knockdown of ULK1, ULK2, and Atg5 increased extracellular 
acidification. The level of extracellular acidification was measured using XF24 
extracellular flux analyzer. Data are presented as percentage relative to scrambled 
shRNA-transduced adipocytes. (D) The expression levels of GLUT1, GLUT4 glucose 
transporter, and GAPDH were analyzed by Western blotting.   Values are mean ± std.  *, 
p < 0.05; **, p < 0.01. Detailed procedures are described in Materials and Methods 
section. 
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4.3. ULK1 or ULK2 are important for mitochondria respiration in adipocytes. 
 
Knowing that ULK1 and ULK2 have effects on fatty acid oxidation, we inquired 
whether the kinases regulate the function of mitochondria.  To determine the effects of 
ULK1 and ULK2 knockdown on mitochondrial function, we examined a variety of 
metabolic parameters linked to mitochondria (Curtis JM 2010). First, we evaluated 
markers of mitochondrial biogenesis at protein, mRNA and DNA levels.  The expression 
of the key transcription factors Tfam, eNOS, and PGC-1α involved in mitochondrial 
biogenesis were greatly increased by ULK1 and ULK2 knockdown (Fig. 20A).  
Consistent with the increased expression of the genes regulating mitochondria 
biogenesis, the abundance of COX II gene was significantly increased by ULK1, ULK2 
or Atg5 knockdown (Fig. 20B). These results indicate that the accumulation of damaged 
mitochondria which are not cleared by autophagy was more severe in ULK1 knockdown 
compared to ULK2 or Atg5 knockdown.   
 
Interestingly, among the antioxidant response genes, the expression levels of GSTA4 
and NQO-1 were increased in ULK2- or Atg5- silenced adipocytes whereas the 
expression level of NRF2 was increased by ULK1 or ULK2 knockdown (Fig. 20C). This 
result suggests that ULK1, ULK2 or Atg5 knockdown enhances the expression levels of 
a set of genes involved in mitochondria biogenesis and oxidative stress response which 
are crucial for ameliorating cellular stress caused by ROS and protein oxidation. 
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Knowing the effects of ULK1 and ULK2 on the expression levels of anti-oxidative 
stress genes, we sought to determine whether ULK1 and ULK2 regulate mitochondrial 
respiratory activities.  We measured oxygen consumption rate (OCR) using XF24 bio-
energetic assay instrument from Seahorse bioscience company (Fig. 21A) (Wu M 2007).  
Interestingly, the rest of tracing-respiration profile was dramatically changed by 
knockdown of ULK1, ULK2 or Atg5 compared to control shRNA transduction.  We 
observed that the basal respiration is reduced and the non-mitochondrial respiration is 
increased by knockdown of ULK1, ULK2 or Atg5 (Fig. 21B and D).  The mitochondria 
in ULK1, ULK2 or Atg5-silenced cells had a decreased response to oligomycin A (ATP 
coupler) compared to control cells (Fig. 21C), indicating that mitochondrial function was 
impaired with ULK1, ULK2 or Atg5 knockdown.  
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Figure 20. Knockdown of ULK1 or ULK2 increases expression of genes involved in 
mitochondrial biogenesis and oxidative stress response. (A) Expression of 
transcription factors and target mRNA in mitochondrial biogenesis. (B) Knockdown of 
ULK1, ULK2, or Atg5 enhanced mitochondrial DNA (mtDNA) content.   Total DNA 
was purified from adipocytes and the amount of COX II mitochondrial DNA relative to 
nuclear DNA measured by quantitative PCR. Detailed procedures are described in 
Materials and Methods section. (C) Expression of target mRNA in oxidative stress 
response. Values are mean ± std.  *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
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Figure 21. ULK1 or ULK2 are important for mitochondria respiration in 
adipocytes. (A) ULK1, ULK2 or Atg5 shRNA-transduced adipocytes were subjected to 
energy metabolism analysis using XF24 extracellular flux analyzer. (B) Knockdown of 
ULK1, ULK2 or Atg5 significantly reduced mitochondrial oxygen consumption rates. 
(C) Knockdown of ULK1, ULK2 or Atg5 significantly reduced ATP turnover rates. (D) 
Knockdown of ULK1, ULK2 or Atg5 enhances non-mitochondrial respiration. Values 
are mean ± std.  *, p < 0.05; **, p < 0.01; ***, p < 0.001. Detailed procedures are 
described in Materials and Methods section. 
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4.4. ULK1 and ULK2 are important for protecting adipocytes from oxidative stress 
and apoptotic cell death. 
 
Dysfunction of mitochondria is the major source of ROS and oxidative stress (Boudina S 
2005; Scherz-Shouval R 2007; Kim JA 2008; Pauw AD 2009). Consistent with the 
reduced efficiency in the respiration and increased non-mitochondrial respiration (Fig. 
21A and B), knockdown of ULK1 or ULK2 in adipocytes exhibited a significant 
increase in ROS (Fig. 22A).  To confirm that the increase in the level of ROS is due to 
dysfunctional mitochondria, we isolated mitochondria from the cells and analyzed the 
level of ROS per mitochondria.  Knockdown of ULK1, ULK2 or Atg5 enhanced the 
production of ROS per mitochondrion (Fig. 22B), suggesting that dysfunctional 
mitochondria contributed to the increase in the ROS.  Knockdown of ULK1, ULK2 or 
Atg5 also increased protein carbonylation (Fig. 22C), a covalent modification reflecting 
protein oxidation (Grimsrud PA 2007). Increased carbonylation of specific proteins was 
noted in ULK1 and ULK2 knockdown relative to control adipocytes.  The prominent 
band near ~15 kDa in adipocytes has previously been identified  as the adipocyte fatty 
acid-binding protein (aP2) (Grimsrud PA 2007; Curtis JM 2010). Other proteins at 20, 
30, 40, and 70 kDa (*) exhibited 2.8, 4.7 or 6.7 folds increase (P < 0.05) in 
carbonylation in the ULK1, ULK2 or Atg5 knockdown cells, respectively (Fig. 22C and 
D). Combined together, these results suggest that ULK1, ULK2 and Atg5 are important 
for mitochondrial functional maintenance thereby suppressing production of ROS and 
oxidative stress. 
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Knowing the crucial function of ULK1 and ULK2 in maintaining mitochondrial function 
and suppressing the production of ROS and oxidative stress, we inquired whether ULK1 
and ULK2 would affect the capacity of adipocytes to respond to oxidative stress.  We 
tested this possibility by incubating the shRNA-transduced adipocytes with tumor 
necrosis factor α (TNFα), the cytokine that induces oxidative stress in adipocytes (Chen 
XH 2010; Curtis JM 2010).  Knowing that ROS and oxidative stress can cause 
impairment in insulin action via activation of p38 mitogen activated protein kinase 
(MAPK) and inhibitor kappaB kinase-beta (IKK2)/NF-kB pro-inflammatory signaling 
(Yuan M 2001; Gao Z 2002; Carlson CJ 2003; Evans JL 2003; de Alvaro C 2004; Nieto-
Vazquez I 2008; Zhang J 2008; Yang J 2009), we investigated whether knocking down 
any of the autophagy genes could increase the pro-inflammatory pathway activities.  We 
found that knockdown of ULK1, ULK2, or Atg5 increased the phopshorylation of p38 
MAPK at Thr180/Tyr182 and processing of NF-kB1 into p50 (Fig. 23). This result 
suggests that autophagy is important to suppress pro-inflammatory signaling under 
oxidative stress.  Consistent with these results, cell death was increased in cells where 
ULK1, ULK2 or Atg5 was knocked down compared to control cells (Fig. 24). This 
result would support that autophagy is important for adipocytes to survive under 
oxidative stress. 
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Figure 22. ULK1 and ULK2 are important for suppressing oxidative stress 
accumulation in adipocytes. (A) Fluorescent probe H2DCFDA was used for whole-cell 
ROS detection in differentiated 3T3-L1 cells (day 8). (B)  Matrix superoxide was measured 
in isolated mitochondria using TPP-HE.  (C) Knockdown of ULK1, ULK2 or Atg5 
increased carbonylation of proteins.  Carbonylation of adipocyte proteins was analyzed 
by use of EZ-link Biotin Hydrazide (BH).  Lane with no BH label is used as a control for 
background carbonylation level.  (D) Quantitative analysis of protein carbonylation.  
The values were obtained from the band intensities for proteins of molecular sizes of 15, 
20, 30, 40, and 70 kDa.  Values are mean ± std.  *, p < 0.05; **, p < 0.01. Detailed 
procedures are described in Materials and Methods section.   
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Figure 23. Autophagy is important to suppress pro-inflammatory signaling under 
oxidative stress.  Knockdown of ULK1, ULK2 or Atg5 increased pro-inflammatory 
signaling.  Cell lysate was obtained from adipocytes at day 10 after induction of 
differentiation in RIPA buffer after treating 20 µM TNFα for 24 hr. NF-kB1 processing 
(p105 → p50) and the phosphorylation state of p38 MAPK at Thr180/Tyr182 were 
analyzed by Western blotting.  
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Figure 24. Knockdown of ULK1, ULK2 and Atg5 increased cell death activities. 
Knockdown of ULK1, ULK2 or Atg5 enhanced apoptosis of adipocytes. Differentiated 
3T3-L1 cells (day 8) were treated with TNFα and then the cell death activity was 
measured by using APO-BrdU TUNEL (Terminal deoxynucleotide transferase dUTP 
nick end labeling) Assay kit.  Values are mean ± std.  *, p < 0.05; **, p < 0.01; ***, p < 
0.001. Detailed procedures are described in Materials and Methods section. 
 
 
71 
 
4.5. Conclusion   
 
My study revealed that knockdown of ULK1 or ULK2 in 3T3-L1 adipocytes inhibited 
mitochondrial respiration, which was accompanied by increases in oxidative stress, pro-
inflammatory signaling and apoptotic cell death.   I also found that ULK1 and ULK2 
negatively regulate mTORC1 signaling.   Knockdown of ULK1, ULK2 or Atg5 reduced 
ATP production from mitochondria and increased glycolysis.  ULK1 knockdown 
enhanced ROS and oxidative stress, which are known key factors contributing to insulin 
resistance (Nishikawa T 2007).  Furthermore, ULK1 knockdown facilitated cell death 
under a prolonged stress condition such as TNFα treatment over 24 h. This result 
suggests that autophagy might be important for adipocytes to survive under oxidative 
stress.  In conclusion, ULK1 and ULK2 share key functions in lipolysis, mitochondrial 
respiration and protection of cells against oxidative stress.   
 
The outcomes suggest that ULK1 knockdown has both beneficial and harmful effects on 
adipocyte metabolism and function.  The beneficial effect may involve an increase of 
insulin-stimulated glucose uptake, whereas the harmful effects involve induction of 
oxidative stress and apoptotic cell death under stress conditions.  These functions of 
ULK1 might be relied on ULK2, since ULK2 is up-regulated in ULK1-silenced 
adipocytes and it has a dominant effect over ULK1 in the regulation of adipogenesis.   
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CHAPTER 5 : Discussion 
 
My study has demonstrated that ULK1 and ULK2 have distinct functions in the 
regulation of metabolism in adipocytes (Fig. 25).  This result appears to be distinct from 
the previously-known function of autophagy role in adipogenesis (Baerga R 2009; Singh 
R 2009; Zhang Y 2009; Goldman S 2010; Kovsan J 2011). A possible interpretation for 
the different effects might be that ULK1 has a unique function of ULK1 in adipogenesis.  
However, we note that autophagy was not completely suppressed in the knocked-down 
cells.  Thus, one would assume that a basal level of autophagy might be necessary and 
sufficient for differentiation while ULK1 negatively regulating differentiation through 
an unknown mechanism.  Knockdown of both ULK1 and ULK2 showed that ULK2 
effect is dominant over ULK1 effect on adipogenesis.  Thus, ULK2 is an important 
component that may constitute the autophagy pathway crucial for adipogenesis.  This 
pathway may involve Atg5/Atg7 but not ULK1.  We wonder how autophagy is still 
inhibited, even though ULK1 expression was dramatically increased in ULK2-silenced 
adipocytes.  This implies that the up-regulation of ULK1 would not necessarily 
contribute to autophagy.  A possible explanation is that ULK1 at extra amounts may not 
be in a functional complex with its binding partners.  Alternatively, ULK2 may have a 
unique function in the autophagy pathway. 
 
ULK2 and Atg5 showed similar effects not only on adipogenesis but also on most of 
other metabolic parameters.  Knockdown of ULK2 or Atg5 in adipocytes inhibited 
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adipogenesis and enhanced fatty acid oxidation (Fig. 13 and 16B).  This result is 
consistent with what was observed with Atg7 deficiency or knockdown (Nishida Y 
2009; Singh R 2009; Zhang Y 2009). It is unclear how ULK1 and ULK2 have different 
effects on fatty acid oxidation and fatty acid synthesis.  The increase in fatty acid 
oxidation by ULK2 or Atg5 knockdown, despite the reduction in the mitochondrial 
respiration, could be possible due to the increase in the content of mitochondria that still 
maintain the intact machinery for fatty acid oxidation.  The increase in glucose uptake 
may be accompanied by glycolysis and fatty acid synthesis with reduced lipolysis and 
fatty acid oxidation.  Alternatively, ULK1 knockdown might specifically suppress the 
expression of genes involved in fatty acid oxidation. According to the change in gene 
expression, it appears that ULK1 and ULK2 regulate different sets of genes involved in 
fatty acid metabolism.  PPAR-γ is likely an important transcription factor involved in the 
different effects by knockdown of ULK1 or ULK2.  ULK1 and ULK2 have not only 
distinct but also similar functions in the regulation of adipocyte metabolism.  
Knockdown of ULK1 or ULK2 enhanced the activity of mTORC1 signaling (Fig. 18A 
and B).  Although ULK1 and ULK2 have the shared function in negatively regulating 
mTORC1 signaling, only the knockdown of ULK1 enhanced the expression levels of 
IRβ and IRS-1 (Fig. 18A and B).  Atg5 knockdown also had a positive effect on 
mTORC1 activity, which is different from what was observed with other cell types (Lee 
SB 2007; Dunlop EA 2011; Jung CH 2011).  This finding suggests that mTORC1 
signaling might not be responsible for the opposing effects of ULK1 and ULK2 on 
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adipogenesis and possibly up-regulation of IRβ and IRS-1 might have contributed to the 
higher level of adipogenesis in ULK1-silenced cells.   
 
Knockdown of ULK1, ULK2 or Atg5 reduced ATP production from mitochondria and 
increased the level of GLUT1, basal glucose uptake and glycolysis (Fig. 19A, C, and D; 
Fig. 21C). The down-regulation of fatty acid oxidation, mitochondrial respiration and 
lipolysis and the up-regulation of glucose uptake are well known to correlate with 
mitochondrial dysfunction (Lowell 2005).  Why would autophagy-defective adipocytes 
become more dependent on glycolysis which is less efficient in producing energy?  This 
might be related to accumulation of damaged mitochondria.  Autophagy-defective 
adipocytes may depend less on mitochondria but more on glycolysis to produce energy.  
Through such a metabolic change, adipocytes may avoid further accumulation of the 
ROS and oxidative stress.  ULK1 showed a distinct effect from ULK2 and Atg5 in the 
regulation of GLUT4 expression and insulin-sensitive glucose uptake.  The increase in 
insulin-stimulated glucose uptake might be potentially related to the up-regulation of 
GLUT4, IRβ and IRS-1 (Fig. 18A and B; Fig. 19D). The increase in the levels of IRβ 
and IRS-1 in ULK1-silenced adipocytes did not contribute to an increase in Akt 
activation (Fig. 18). Thus, if IRβ and IRS-1 contributed to insulin-stimulated glucose 
uptake, it must be through a mechanism independent of Akt. Although the result above 
supports a function of ULK1 in the regulation of insulin-stimulated glucose uptake in 
adipocytes, ULK1 knockdown enhanced ROS and oxidative stress (Fig. 22 and 23), 
which are known key factors contributing to insulin resistance (Nishikawa T 2007).  
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Furthermore, ULK1 knockdown facilitated cell death under a prolonged stress condition 
such as TNFα treatment over 24 h (Fig. 24). Thus, ULK1 knockdown has both 
beneficial and harmful effects on adipocyte metabolism and function.  The beneficial 
effect may involve an increase of insulin-stimulated glucose uptake, whereas the 
harmful effects involve induction of oxidative stress and apoptotic cell death under 
stress conditions.  These functions of ULK1 might be relied on ULK2, since ULK2 is 
up-regulated in ULK1-silenced adipocytes and it has a dominant effect over ULK1 in 
the regulation of adipogenesis.  
 
According to our study, the increase in the activity of adipocyte autophagy in diabetic 
and obese states (Zhang Y 2009; Zhou L 2009; Ost A 2010; Kovsan J 2011)  could be 
due to a cellular protective mechanism against the metabolic stress, rather than due to 
any causative effect of autophagy on the development of such disease states.  This 
protective function of autophagy might be important especially when adipocytes are 
under metabolic stress. Given the opposing effects and the reciprocal compensatory 
relation between ULK1 and ULK2, a currently-unknown mechanism might exist to 
coordinately regulate the ULK1- and ULK2-dependent pathways to determine insulin 
sensitivity and stress response of adipocytes. Further studies on the function of ULK1 
and ULK2 in adipocytes might provide important insight into the role of ULK and 
autophagy in the pathophysiology of obesity and related diseases.  
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Figure 25. A summary for the role of ULK1 and ULK2 kinases in adipocyte 
metabolism. ULK1 and ULK2 have shared functions in the regulation of mTOC1 
signaling, lipolysis, mitochondrial function, and oxidative stress response through 
autophagy or mitophagy. On the other hand, ULK1 has distinct functions in the 
regulation of glucose metabolism and insulin signaling by inhibiting GLUT4, IRβ, and 
IRS-1 whereas ULK2 has distinct function in the regulation of lipid metabolism by 
positively regulating adipogenesis and fatty acid synthesis and negatively regulating 
fatty acid oxidation through PPAR-γ and CEBP-α.  This result also suggests that ULK2, 
rather than ULK1, is more closely related to Atg5 in adipocytes. In sum, this study 
provided the distinct and shared functions between ULK1 and ULK2 in comparison with 
Atg5 in adipocyte metabolism. 
 
 
 
 
 
 
 
 
 
 
78 
 
CHAPTER 6 : Future directions 
 
Although this study has provided important insight into the role of ULK and autophagy 
in the regulation of adipogenesis and adipocyte metabolism, there remain many 
questions with respect to the underlying mechanisms. How ULK1 negatively regulates 
adipogenesis?  How could ULK1 and ULK2 be distinctly regulated?  Is this function 
related to autophagy or not?  How can this study and the obtained knowledge be useful 
to develop therapeutics for diabetes and obesity?    
 
Given the distinct functions between ULK1 and ULK2, a study to identify their unique 
substrates might be important to elucidate the mechanisms differently regulated by the 
two kinases. Knowing that PPAR-γ is differently regulated by ULK1 and ULK2 (Fig. 
13C), it would also be interesting to investigate what is the underlying mechanism that 
leads to the difference in the regulation. PPAR-γ is regulated by PGC-1α, which is the 
coactivator of PPAR-γ, inducing gene expressions of adipocyte differentiation and 
increasing mitochondria mass and function (Liang H 2006; Medina-Gomez G 2007; 
Tontonoz P 2008).  It might be possible that ULK1 and ULK2 regulate these 
transcriptional factors through phosphorylation of currently-unknown intermediate 
molecules that regulate the transcriptional factors.   
 
In future studies, mouse models would be important to understand the physiological 
meaning of our findings.  Currently, ULK1 KO mouse model is available.  ULK1 fl/fl 
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mice are also available and have been used to generate adipose specific ULK1 KO mice.  
These mice would be important resources in addressing the questions imposed above 
and providing important insight into the physiological roles of these kinases and 
adipocyte autophagy in the regulation of adipose metabolism. These mice would also 
allow us to investigate how ULK1- or ULK2-regulated autophagy in adipose tissue 
regulates energy metabolism in peripheral tissues and the whole body level. Ultimately, 
these studies may contribute to better understanding of the function of autophagy in 
obesity and insulin resistance. 
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CHAPTER 7 : Materials and Methods 
 
Mouse tissue sample preparation. Male mice strain C57BL/6J were fed normal chow 
(~ 4% fat by weight, Teklad) or high fat diet (~35 % fat by weight, F3282, BioServ) at 
weaning (Surwit RS 1988). Mice were housed on a 12-h light/dark cycle and fed ad 
libitum with continual access to water. At 12 weeks of age, they were weighing 34-49 g 
and 26-33 g, respectively. Each group of mice were fasted for 4 h and euthanized by 
carbon dioxide, and epididymal white adipose tissues were excised. Fat tissue were 
immediately frozen in liquid nitrogen and stored at -80 °C until further processing. The 
University of Minnesota Institutional Animal Care and Use Committee approved all 
experiments. 
 
Antibodies and chemicals. Primary antibodies were from the following sources: anti-
insulin receptor β (3025), anti-insulin receptor substrate-1 (IRS-1, 2382), anti-Akt 
(9272), anti-phospho-Akt (9271), S6K1 (9202), anti-phospho-S6K1 (9205) and anti-p38 
(9212) from Cell Signaling Tech (Danvers, MA); anti-CEBP-α (sc-61), anti-PPAR-γ 
(sc-7196), anti-GAPDH (sc-25778), anti-tubulin (sc-12462) from Santa Cruz Biotech. 
(Santa Cruz, CA); anti-Atg5 antibody (110-53818) from Novus Biologicals (Littleton, 
CO); anti-ULK1 (A7481) from Sigma-Aldrich; anti-β-actin (612657) from BD 
Biosciences; anti-GLUT4 (AB1346) from Chemicon.  GLUT1 antibody was kindly 
provided by Dr. Xiaoli Chen (University of Minnesota).  Chemicals were purchased 
from the following sources: rapamycin (553210, EMD Chemicals); insulin (I6634), 
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methylisobutylxanthine (I5879), dexamethasone (D4902), troglitazone (T2573), Oil Red 
O (0625), pepstatin A (P5318), cytochalasin B (C6762), puromycin (82595), forskolin 
(F3917), and E-64 (E3132) from Sigma-Aldrich; 4,4-difluoro-5-methyl-4-bora-3a,4a-
diaza-s-indacene-3-dodecanoic acid (BODIPY) (D3823), DAPI (D1306), chloromethyl 
2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA) (C6827), TRIzol reagent 
(15596-018), APO-BrdU Terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) Assay kit (A35125 and A35126), LysoTracker Red (L7528)  from Invitrogen; 
EZ-link Biotin Hydrazide (21339, Pierce); NEFA-HR (999-34691,995-34791,991-34891, 
and 993-35191) from Wako diagnostics; Oligomycin A, Carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone (FCCP), and antimycin A from Seahorse 
Bioscience (101706-110); RNase free DNAse I (AM2222, Ambion); iScript cDNA 
Synthesis Kit (170-8891) and iQ SYBR Green Supermix (170-8880) from Bio-Rad; 2.5 
% glutaraldehyde, sodium cacodylate, Osmium tetroxide, tannic acid, ethanol: embed 
812 resin, and 20 mm gelatin capsules from Electron Microscopy Sciences (Hatfield, 
PA); Mouse tumor necrosis factor  α (mTNFα) (5178) from Cell Signaling Tech 
(Danvers, MA). 
 
Quantitative real-time RT-PCR. Total RNAs from isolated adipose cells from mouse 
epididymal fat depot, 3T3-L1 adipocytes were extracted using TRIzol reagent (15596-
018, Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. RNA was 
treated with RNase free DNAse I (AM2222, Ambion) at 37ºC for 30 min, followed by 
extraction with phenol-chloroform and ethanol precipitation. The first-strand cDNA was 
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generated using iScript cDNA Synthesis Kit (170-8891, Bio-Rad, Hercules, CA) was 
used in each 20 µl real-time PCR reaction using the iQ SYBR Green Supermix (170-
8880, Bio-Rad) with ICycler Real Time PCR System (Bio-Rad). Primers specific for the 
examined genes are listed (Table 1). β-Actin or TFIIE was selected as an internal 
standard. Results were analyzed using iQ5 software supplied with the ICycler system. 
All raw data are expressed as the ratio of the selected gene to standard. Statistical 
significance was determined by two-tailed Student’s t test.  
 
Lentiviral preparation, viral infection and stable cell line generation. 
Oligonucleotides for sh-RNA targeting GFP scrambled, ULK1, ULK2, and Atg5 were 
annealed and cloned into pLKO shRNA vectors (Table 2). Lentiviral stocks were 
produced by transfecting pLKO shRNA vectors with lentiviral packaging vectors 
pHR’8.2ΔR and pCMV-VSV-G using Fugene 6 (Invitrogen) into HEK-293T cells. 
Supernatants were harvested over 60 hours. 3T3-L1 cells grown on 6-cm dishes were 
infected with collected viruses four times over 15 h in the presence of polybrene (Sigma-
Aldrich). Selection for cells transduced by shRNA lentiviruses to knockdown 
endogenous mouse ULK1, ULK2 or Atg5 was performed in the presence of 2.5 μg/ml 
puromycin (82595, Sigma-Aldrich). Expression levels of ULK1 or Atg5 in stable cell 
lines were analyzed on western blots using anti-ULK1 or anti-Atg5 antibodies. ULK2 
knock down was confirmed by RT-PCR. 
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Adipocyte differentiation, lipid staining, and triglyceride measurements. 3T3-L1 
preadipocytes were cultured and differentiated into adipocytes as described previously 
(Student AK 1980). Preadipocytes were cultured in DMEM containing 10 % calf serum. 
Two days after reaching confluence, cells were induced to differentiate in DMEM 
supplemented with 10 % FBS, 174 μM insulin (I6634, Sigma-Aldrich), 0.5 mM 
methylisobutylxanthine (I5879, Sigma-Aldrich), and 0.25 μM dexamethasone (D4902, 
Sigma-Aldrich). Two days after initiation of differentiation, dexamethasone and 
methylisobutylxanthine were withdrawn from the medium, whereas insulin was 
withdrawn after 4 days. Differentiated adipocytes were maintained in DMEM and 10 % 
FBS until mature (days 8-10). For full differentiation of autophagy gene silenced 3T3-
L1 cells, 5 μM troglitazone (T2573, Sigma-Aldrich) was treated along with 
differentiation inducing chemicals, and then lipid droplets were stained using Oil Red O 
(0625, Sigma-Aldrich) solutions. To measure intracellular triglyceride levels, Oil Red O 
was extracted from cells with isopropanol, and optical density was then measured at a 
wavelength of 490 nm. Triglyceride levels were normalized to protein concentration. 
 
Microscopic analysis of autophagosome formation. GFP scrambled, ULK1 Kd, 
ULK2 Kd and Atg5 Kd 3T3-L1 preadipocytes were seeded onto glass coverslips and 
differentiated into adipocytes as described previously (Curtis JM 2010). On day 8, 
Autophagy was induced by 100 nM rapamycin (44532-U,Sigma-Aldrich) or vehicle 
(DMSO) in the presence of pepstatin A (P5318,Sigma-Aldrich) and E-64 (E3132, 
Sigma-Aldrich) (10 μg/ml each), an inhibitor of the lysosomal protein degradation. After 
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5 h of induction, cells were fixed with formaldehyde, permeabilized using 1 % Triton X-
100, and stained with anti-LC3 antibody (100-2220) from Novus and 4, 6-
diamidinophenylindole (DAPI) from Invitrogen (D1306). Cells were visualized under a 
confocal microscope attached IX70 inverted microscope (Olympus, Center Valley, PA). 
Multiple fields at random positions were collected for each condition. Quantification of 
LC3-labeled structures in the images was performed by counting the number of cells 
with LC3-positive structures (Klionsky DJ 2008; Klionsky DJ. 2008). 
 
Western blot assay of autophagy. 3T3-L1 adipocytes were incubated with rapamycin 
for 5h in the presence of pepstatin A and E-64 (10 μg/ml each). Cell lysates were 
obtained and run on SDS-PAGE and transferred to polyvincylidene difuoride 
membranes and probed with anti-LC3 mouse polyclonal antibody (Nanotools, France) 
and anti-p62 antibody (610832, BD Biosciences). 
 
Immunoblot analysis. For analysis of proteins in autophagy and insulin signaling, 
adipose cells was lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 10 mM MgCl2, 500 
mM NaCl, 1 % Triton X-100, 0.1 % SDS, 0.5 % deoxycholate, and protease inhibitors 
[Complete; Boehringer Mannheim]) followed by centrifugation (13000 rpm; 10 min; 
4ºC). Protein content of supernatants was determined using the BCA kit (Thermo 
Scientific). A total of 30 μg protein was analyzed by immunoblotting for expression of 
autophagy proteins (ULK1, Atg5), insulin signaling proteins [IRβ, IRS-1, Akt, p-Akt, 
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S6K1, p-S6K1] by antibodies purchased from previously noted companies. Insulin was 
dissolved in 0.02 N HCl for treatment (I6634, Sigma-Aldrich). 
 
Electron microscopy imaging. Cells on thermonox cover slips (Thermo Scientific, 
Rochester, NY, USA) were fixed in 1 ml of 2.5 % glutaraldehyde in 0.1 M sodium 
cacodylate buffer in 6 well plates overnight at 4°C.  The cells on thermonox cover slips 
were washed three times with 0.1 M sodium cacodylate buffer and post fixed with 1% 
osmium tetroxide in 0.1 M sodium cacodylate buffer. Followed by incubation in 1% 
tannic acid, these samples were washed in distilled water and dehydrated using a 25-100 
% ethyl alcohol gradient. Samples were then infiltrated with 2:1 ethanol: Embed 812 
resin for 1 hour and subsequently transferred to a 1:2 ethanol: Embed 812 resin mixture 
for 1 hour.  Cells on thermonox cover slips were infiltrated with 100 % resin and were 
embedded on top of 20 mm gelatin capsules and incubated at 58oC for 24 hours to 
polymerize the resin.  Embedded samples were trimmed and sectioned on a Leica UC6 
Ultramicrotome (Leica Microsystems, Vienna, Austria).  Thin sections (60-70 nm) were 
obtained and collected on a 200 mesh copper grid (Electron Microscopy Sciences, 
Hatfield, PA, USA) using a perfect loop.   Grids were stained with 5% uranyl acetate for 
20 minutes and Satos’ lead citrate for 6 minutes.  These sections were observed in the 
JEOL 1200 EX II transmission electron microscope (JEOL LTD, Tokyo, Japan).  
Images were obtained using a Veleta 2K x 2K camera with iTEM software (Olympus 
SIS, Munster, Germany).  The autophagosome structures indicated by red arrows were 
visually identified with characteristics of protein aggregates or cellular compartments 
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within double membrane-structures. The total number of autophagosomes of 10 
randomly selected cells was counted.  In each cell, up to 10 autophagosomes were 
randomly selected and their perimeter and area were measured and recorded using the 
iTEM software (Olympus SIS).  
 
Glucose uptake assay. 3T3-L1 adipocytes were serum-starved in Krebs–Ringer's Hepes 
buffer (130 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 1.3 mM MgSO4, and 25 mM Hepes 
pH 7.4) supplemented with 0.5 % BSA and 2 mM sodium pyruvate (pH 7.4) and 
incubated either with or without 100 nM insulin for 1 hr at 37°C. Glucose uptake was 
initiated by the addition of [3H]-2-deoxy-D-glucose (PerkinElmer Life and Analytical 
Sciences, Boston, MA) to a final assay concentration of 100 μM at 37ºC. After 5 min, 2-
deoxyglucose uptake was terminated by three washes with ice-cold Krebs-Ringer’s 
Hepes buffer, and the cells were solubilized with 0.8 ml of Krebs-Ringer’s Hepes buffer 
containing 1 % Triton X-100. The incorporated radioactivity was determined by 
scintillation counting. Nonspecific 2-deoxyglucose uptake was measured in the presence 
of 20 μM cytochalasin B (C6762, Sigma-Aldrich) and subtracted from the total glucose 
uptake assayed to determine specific uptake (Lobo S 2007). 
 
Lipolysis assay. To evaluate lipolysis, 3T3-L1 adipocytes were washed with phosphate-
buffered saline (PBS) and incubated at 37ºC in KRH supplemented with 2 % fatty acid-
free BSA and 5 mM glucose with or without 40 μM forskolin. Media was collected after 
one hour and the non-esterifed fatty acids determined using the NEFA-HR (Student AK 
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1980) assay according to the manufacturer’s instructions (Wako Diagnostics, Mountain 
View, CA, USA). 
 
Microscopic analysis for autophagic clearance of lipid droplets. 3T3-L1 
preadipocytes cells seeded onto glass coverslips. After fully differentiated (day 8), 
medium was refreshed with serum free DMEM or DMEM containing 10% FBS serum. 
Macroautophagy was induced by serum starvation in the presence of pepstatin A and E-
64 (10 μg/ml each), an inhibitor of the lysosomal protein degradation (Sigma). After 2h 
of induction, cells were fixed with formaldehyde, permeabilized using 1% Triton X-100 
for 15 min at RT. Lysosomes were stained with 100 nM lysotracker Red (Invitrogen) for 
30 min at RT, then lipid droplets were labeled with 1 μg/ml BODIPY 493/503 
(Molecular probes) and nucleus were labeled with 4, 6-diamidinophenylindole (DAPI) 
each for 1 min at RT. Glass coverslips were washed with PBS three times. Engulfment 
of lipid droplets by autophagosome were visualized under high magnification (100X) of 
a confocal microscope attached IX70 inverted microscope (Olympus). 
 
Fatty acid β-oxidation. 3T3-L1 adipocytes were serum-starved for 2h, and 
subsequently incubated in DMEM containing 5.4 mM glucose, 4 mM glutamine, 1% 
fatty acid-free BSA, and 0.25 mM oleate. β-oxidation was initiated upon addition of 0.2 
mM [1-14C]-oleic acid (0.8 μCi/ml) buffered with 1% FA-free BSA and incubated for 90 
min at 37 ºC and 5% CO2 (Lobo S 2007). Each well was covered immediately by a 
piece of square shape Whatman paper. After incubation, 150 μl of 3 M NaOH was added 
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on the paper and then 70 % perchloric acid was injected into wells. Filter papers 
containing trapped CO2 from each well were transferred to liquid scintillation fluid 
and 14CO2 content was determined. 
 
Mitochondrial DNA quantification. To determine mitochondria DNA levels, total 
genomic DNA was isolated with DNAzol reagent (Invitrogen), and the amount of 
mtDNA was compared with nuclear DNA. mtDNA copy number was measured by 
means of quantitative PCR of mtDNA gene cytochrome C oxidase II (COXII) compared 
to the nuclear gene as described ((Piantadosi CA 2006; Grimsrud PA 2008)). mtDNA 
copy number was calculated by taking the absolute value of ΔCt values between groups 
(scrambled vs. knockdown). 
 
Respiration of mitochondria and glycolysis. Oxygen consumption rate (OCR) and 
Extracellular acidification rate (ECAR) in scrambled, ULK1, ULK2 or Atg5 silenced 
adipocytes were measured by XF24 bioenergetic assay (Seahorse Bioscience, Billerica, 
MA, USA). Assays have been previously described in detail (Wu M 2007). Oligomycin 
A, Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), and Antimycin A 
were purchased from Seahorse Bioscience (101706-110, XF cell mito-stress test kit, 
Seahorse Bioscience).  
 
Measurement of intracellular ROS.  Intracellular ROS levels were measured using the 
chloromethyl 2’,7’-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) (C6827, 
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Invitrogen), a cell permeable nonfluorescent precursor. This dye measures H2O2, ROO−, 
and ONOO−. Within the cells, CM-H2DCFHDA is hydrolyzed by nonspecific esterases 
to release CM-H2DCF, which is readily oxidized by intracellular ROS. The oxidized 
product emits green fluorescence with a wavelength of 516 nm after excitation with a 
wavelength of 492 nm (Ex.492/Em.516). The protocol was modified from manufacture’s 
instruction. Briefly, ULK1, ULK2 or Atg5 silenced preadipocytes were cultured and 
differentiated on 24 well microplates (PerkinElmer). 3T3-L1 adipocytes (day 8) were 
loaded with 5 μM of fluorescent probe CM-H2DCFDA for 30 min at 37ºC. Cells without 
fluorescent probe were used as control.  Cells were washed with PBS three times before 
measurement. The fluorescence intensity was measured by VICTOR3V Multilabel 
Counter 1420 (PerkinElmer). The measured values were normalized by protein 
concentration. All experiments were performed in triplicate. 
 
Mitochondria isolation and matrix superoxide measurement.  3T3-L1 adipocytes 
were collected and incubated for 20min on ice in 20mM Tris pH 6.8 and 1 mM EDTA 
containing protease inhibitors. Cells were lysed with 40 strokes of a Dounce 
homogenizer, and the resulting homogenate was supplemented with a final concentration 
of 220 mM mannitol and 70 mM sucrose. For mitochondrial isolation from adipocytes, 
cells were washed in ice-cold Krebs-Ringer’s Hepes, and lysed with 1:5 wt/vol of 
isolation buffer (20 mM Tris-HCl, 220 mM mannitol, 70 mM sucrose, 1 mM EDTA, pH 
7.4 supplemented with protease inhibitors) by Dounce homogenization. Homogenates 
were centrifuged at 700g to remove nuclei, unbroken cells, and the lipid cake. 
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Mitochondria were recovered by centrifugation at 12,000g. TPP-HE was used to detect 
superoxide in isolated mitochondria as described previously (Xu X 2009). Superoxide 
level was normalized to mitochondrial protein. 
 
Protein carbonylation. Protein carbonylation was detected using EZ-link Biotin 
Hydrazide (21339, Pierce, Rockford, IL) as described previously (Grimsrud PA 2007), 
with slight modifications. Polyvinylidene fluoride membranes (Millipore, Billerica, MA) 
were blocked in Odyssey Blocking Buffer (LI-COR, Lincoln, NE), and biotinylated 
proteins were detected with DyLight 800-conjugated streptavidin (Pierce) and visualized 
using an Odyssey Infrared Imager (LI-COR).  
 
Apopotsis assay. APO-BrdU TUNEL (Terminal deoxynucleotide transferase dUTP nick 
end labeling) Assay kit was purchased from Invitrogen (A35125 and A35126). 3T3-L1 
adipocytes (day 8) were treated with 20 μM TNFα for 24h. Then cells were washed with 
PBS and fixed with paraformaldehyde in PBS for 15 min on ice. Then cells were washed 
with cold PBS twice and stored in 70% Ethanol at -20ºC for 24h. Cells then washed 
twice with washing buffer followed by incubation with DNA-labelling solution 
(containing reaction buffer, terminal deoxynucleotidyl transferase (TdU), BrdUTP with 
dH2O) for 60 min in 37ºC incubator, followed by 30 min incubation with Alexa fluor 
488 dye-labeled anti-BrdU antibody (1:20 dilution) as previously described (Lin J 2004). 
Labeled cells were washed with PBS three times, and the fluorescence excitation and 
emission (492 nm/516 nm) were measured using VICTOR3 V Multilabel Counter model 
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1420 (PerkinElmer). The measured values were normalized by protein concentration. 
All experiments were performed in triplicate. 
 
Statistical analysis. All values are expressed as mean ± standard deviation (std.). 
Statistical significance was determined by the two-tailed Student t test assuming unequal 
variances using Microsoft Office Excel or Sigma Plot (Jandel Scientific). P values < 
0.05 are considered significant (*) with an increased significance of P value < 0.01 
indicated (**) or P value < 0.001 indicated (***). 
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Table 1. Primers used for quantitative real-time PCR (qPCR). The forward (F) and 
reverse (R) primers for all the Mus musculus mRNAs or DNAs quantified by qPCR are 
indicated.  
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Table 2. Oligonucleotides for shRNA target sequences. GFP scrambled, ULK1 (#755), 
ULK1 (#768), ULK2 (#695), and Atg5 (#hp-2 from (Lum JJ 2005)) are targeted for 
knockdown. 
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